Direct Thrombin Inhibitors Versus LMWH in Staphylococcus Aureus Bacteraemia
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
Safety and efficacy of direct thrombin inhibitors versus enoxaparin in patients with
staphylococcus aureus bacteraemia.
The study hypothesizes that inhibition of the coagulase-activity of S. aureus by direct
thrombin inhibitors is safe and translates into a better outcome of patients with S. aureus
bacteremia.